Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹741 Cr.
Stock P/E
22.9
P/B
1.2
Current Price
₹169.5
Book Value
₹ 137.2
Face Value
5
52W High
₹209.3
52W Low
₹ 55.7
Dividend Yield
0%

Kanoria Chem. & Inds Overview

Business

Kanoria Chemicals & Industries Ltd. (KANORICHEM) is an Indian chemical manufacturing company primarily engaged in the production of various industrial and specialty chemicals. Its core business revolves around manufacturing and selling products like Formaldehyde, Hexamethylenetetramine (HMTA), Pentaerythritol, Sodium Formate, and Acetaldehyde. These chemicals serve as crucial raw materials and intermediates for a wide range of end-user industries including plastics, synthetic resins, agrochemicals, pharmaceuticals, dyes, leather, textiles, paints, and construction. The company operates on a B2B model, supplying its products to other industrial consumers. It makes money by producing these chemicals efficiently and selling them to a diverse customer base across various industrial sectors.

Revenue Mix

Kanoria Chemicals & Industries Ltd. primarily operates within a single 'Chemicals' segment. Within this, its revenue is generated from the sale of its key product groups:

Formaldehyde & Derivatives: Includes Formaldehyde and Hexamethylenetetramine (HMTA).

Performance Chemicals: Includes Pentaerythritol and Sodium Formate.

Basic Chemicals: Includes Acetaldehyde.

Specific revenue contributions from each product group are typically not disclosed granularly in public reports, but these product categories represent their core revenue streams.

Industry

KANORICHEM operates within the Indian Chemicals sector, specifically in the manufacturing of basic and specialty chemicals. The industry is diverse, encompassing a wide array of products serving numerous end-user sectors. For basic chemicals like Formaldehyde and Acetaldehyde, the industry can be price-sensitive and competitive, with both large diversified players and smaller, specialized manufacturers. In products like HMTA and Pentaerythritol, Kanoria Chemicals holds a significant position, often being among the largest producers in India, indicating a strong market share in these specific niches. The Indian chemical industry is characterized by increasing domestic demand, backward integration efforts, and a push towards specialty chemicals.

MOAT

Kanoria Chemicals' competitive advantages are primarily derived from:

Scale and Cost Efficiency: For its core products like Formaldehyde, HMTA, and Pentaerythritol, the company has established significant production capacities, which can lead to economies of scale and cost efficiencies in manufacturing processes, providing a pricing edge in commodity-like markets.

Established Customer Relationships: A long operational history has allowed them to build strong, enduring relationships with key industrial customers across various sectors, ensuring consistent demand.

Technical Expertise & Reliability: Consistent product quality and reliable supply are crucial for industrial chemical buyers, where the company has built a reputation over decades.

Strategic Plant Locations: Having manufacturing facilities strategically located can provide logistics advantages in serving key industrial hubs.

Growth Drivers

Key factors that can drive growth for Kanoria Chemicals over the next 3-5 years include:

Domestic Industrial Growth: Robust growth in end-user industries such as housing, construction, automotive, pharmaceuticals, agrochemicals, and textiles in India will directly drive demand for the company's chemicals.

Capacity Expansion: Ongoing and planned capital expenditure projects to increase production capacities for key products like Formaldehyde and Pentaerythritol are expected to boost sales volumes.

Product Portfolio Enhancement: Potential for diversification into higher-value specialty chemicals or new derivatives that cater to evolving industrial needs.

Exports: Leveraging competitive production costs to increase exports to global markets, thereby expanding its customer base beyond India.

Backward Integration: Any efforts towards securing raw material supplies or reducing input costs through backward integration could enhance profitability and competitiveness.

Risks

Raw Material Price Volatility: Significant fluctuations in the prices of key raw materials (e.g., Methanol for Formaldehyde, Acetaldehyde) can severely impact production costs and profit margins.

Intense Competition: The chemical industry is competitive, and pressure from domestic and international players can lead to pricing pressures and margin erosion.

Environmental Regulations: Stringent environmental norms and compliance costs can increase operating expenses, require significant capital investments, or even lead to production curtailments.

Demand Cyclicality: Demand for its products is linked to the performance of various industrial sectors, which can be cyclical, leading to volatility in sales and profitability.

Foreign Exchange Fluctuations: Given potential imports of raw materials or exports of finished goods, currency rate movements can impact profitability.

Operational Risks: Risks associated with chemical manufacturing, such as plant breakdowns, accidents, or supply chain disruptions.

Management & Ownership

Kanoria Chemicals & Industries Ltd. is promoted by the Kanoria family, which has a long-standing presence in the Indian industrial landscape. The promoters generally hold a significant stake in the company, reflecting their long-term commitment and control. The management team includes professionals with experience in the chemical industry. Corporate governance practices typically adhere to Indian regulatory standards. Promoter-driven companies in India often exhibit a focus on long-term sustainability and growth, often through internal accruals and strategic expansions.

Outlook

Kanoria Chemicals is a well-established player in critical segments of the Indian chemical industry, benefiting from the country's overall industrial growth trajectory. Its strong market position in specific products like HMTA and Pentaerythritol, coupled with ongoing capacity expansions, positions it to capture rising domestic demand. However, the company remains susceptible to the inherent cyclicality and volatility of the chemical sector, particularly concerning raw material price fluctuations and intense competition. Its future performance will largely depend on successful execution of expansion projects, effective raw material sourcing strategies, and its ability to navigate the evolving regulatory and competitive landscape while potentially diversifying into higher-margin products.

Kanoria Chem. & Inds Share Price

Live · BSE / NSE · Inception: 1960
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Kanoria Chem. & Inds Quarterly Results

#(Fig in Cr.) Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 361 384 177 180 214 201 210 266 304 460
Other Income 1 1 12 1 3 1 12 2 7 7
Total Income 362 385 188 181 217 202 222 268 312 467
Total Expenditure 333 382 176 165 201 183 204 246 277 415
Operating Profit 29 3 12 16 15 19 19 22 34 52
Interest 12 11 8 8 7 7 9 8 8 7
Depreciation 15 15 8 8 8 9 9 9 9 9
Exceptional Income / Expenses 0 0 0 0 -29 0 0 0 0 0
Profit Before Tax 2 -23 -4 -0 -30 3 1 6 17 35
Provision for Tax 18 1 7 2 2 3 3 2 -15 9
Profit After Tax -15 -24 -11 -2 -32 -1 -2 4 32 26
Adjustments 6 7 -3 -15 -5 -7 96 0 0 0
Profit After Adjustments -9 -17 -14 -17 -36 -8 93 4 32 26
Adjusted Earnings Per Share -2.1 -3.8 -3.2 -3.8 -8.3 -1.8 21.4 0.8 7.2 6

Kanoria Chem. & Inds Profit & Loss

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Net Sales 565 702 837 1072 1005 1095 1369 1578 1475 754 981 1240
Other Income 20 26 45 13 24 16 29 15 19 18 25 28
Total Income 586 728 882 1084 1029 1111 1398 1593 1494 772 1006 1269
Total Expenditure 539 676 802 1008 979 1005 1301 1511 1423 723 912 1142
Operating Profit 47 52 80 76 50 106 97 83 72 49 94 127
Interest 14 20 24 36 37 32 27 36 43 31 32 32
Depreciation 34 45 47 49 56 58 57 59 59 32 35 36
Exceptional Income / Expenses 0 -18 0 -5 0 -4 0 0 0 -29 0 0
Profit Before Tax -1 -32 10 -15 -43 11 13 -12 -31 -43 27 59
Provision for Tax 6 -8 -2 5 -11 -5 11 1 21 11 -6 -1
Profit After Tax -7 -24 12 -19 -32 16 2 -13 -52 -54 32 60
Adjustments 0 9 2 5 6 -1 5 4 13 -29 88 96
Profit After Adjustments -7 -15 14 -15 -26 15 7 -9 -38 -84 121 155
Adjusted Earnings Per Share -1.6 -3.4 3.2 -3.4 -5.9 3.3 1.6 -2 -8.8 -19.1 27.6 35.4

Kanoria Chem. & Inds Balance Sheet

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Shareholder's Funds 603 580 588 598 569 587 599 605 601 521 573
Minority's Interest 18 9 6 16 12 8 3 2 16 -10 0
Borrowings 266 266 260 258 338 345 343 320 297 344 183
Other Non-Current Liabilities 78 64 59 62 51 46 49 46 67 73 52
Total Current Liabilities 259 291 365 466 404 375 409 509 509 571 309
Total Liabilities 1225 1209 1278 1401 1374 1362 1403 1481 1490 1498 1117
Fixed Assets 512 743 800 850 894 864 863 882 850 865 727
Other Non-Current Assets 381 129 82 95 45 39 33 27 78 67 105
Total Current Assets 331 338 395 456 434 459 504 569 556 560 279
Total Assets 1225 1209 1278 1401 1374 1362 1403 1481 1490 1498 1117

Kanoria Chem. & Inds Cash Flow

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Opening Cash & Cash Equivalents 33 18 16 11 19 36 32 19 19 12 4
Cash Flow from Operating Activities 12 30 27 22 31 82 83 26 38 17 71
Cash Flow from Investing Activities -109 7 -21 -86 -3 -12 -43 -29 -50 -20 -8
Cash Flow from Financing Activities 82 -39 -11 73 -11 -75 -53 3 5 -5 -58
Net Cash Inflow / Outflow -15 -2 -5 8 17 -4 -13 -0 -8 -8 6
Closing Cash & Cash Equivalent 18 16 11 19 36 32 19 19 11 4 10

Kanoria Chem. & Inds Ratios

# Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Earnings Per Share (Rs) -1.65 -3.38 3.22 -3.42 -5.9 3.32 1.56 -2.01 -8.79 -19.13 27.64
CEPS(Rs) 6.21 4.98 13.32 6.86 5.61 16.94 13.6 10.54 1.74 -5.17 15.46
DPS(Rs) 1.5 1.5 1.5 0.75 0 0 1 0 0 0 0
Book NAV/Share(Rs) 137.97 132.75 134.56 136.97 130.11 134.4 137.09 138.56 137.61 119.2 131.12
Core EBITDA Margin(%) 4.43 3.59 4.1 5.92 2.58 8.17 4.98 4.3 3.54 4.15 7.05
EBIT Margin(%) 2.1 -1.56 3.96 1.96 -0.61 4 2.91 1.51 0.83 -1.59 5.97
Pre Tax Margin(%) -0.23 -4.32 1.14 -1.4 -4.26 1.04 0.96 -0.77 -2.09 -5.71 2.71
PAT Margin (%) -1.2 -3.23 1.37 -1.82 -3.14 1.46 0.16 -0.82 -3.51 -7.22 3.3
Cash Profit Margin (%) 4.54 2.97 6.89 2.8 2.44 6.76 4.34 2.92 0.52 -2.99 6.88
ROA(%) -0.65 -1.95 0.93 -1.46 -2.27 1.17 0.16 -0.89 -3.48 -3.65 2.48
ROE(%) -1.31 -4.01 1.98 -3.29 -5.41 2.77 0.38 -2.14 -8.57 -9.71 5.92
ROCE(%) 1.35 -1.13 3.3 1.97 -0.55 4 3.71 2.18 1.1 -1.08 5.93
Receivable days 49.58 50.27 54.45 48.25 52.61 57.86 50.18 42.66 47.17 102.42 69.04
Inventory Days 47.68 45.6 52.77 56.48 67.51 58.01 56.06 61.45 69.62 128.51 65.5
Payable days 59.15 59.86 71.53 69.54 82.22 78.42 69.37 71.98 83.26 153.8 93.94
PER(x) 0 0 20.43 0 0 27.42 87.12 0 0 0 2.03
Price/Book(x) 0.39 0.52 0.49 0.46 0.18 0.68 0.99 0.77 0.77 0.63 0.43
Dividend Yield(%) 2.8 2.16 2.28 1.2 0 0 0.73 0 0 0 0
EV/Net Sales(x) 1.08 0.95 0.81 0.69 0.59 0.78 0.76 0.6 0.65 1.21 0.53
EV/Core EBITDA(x) 12.97 12.74 8.5 9.69 11.96 8.08 10.74 11.49 13.36 18.45 5.55
Net Sales Growth(%) 6.44 24.22 19.19 28.08 -6.25 8.97 25.05 15.29 -6.55 -48.86 30.11
EBIT Growth(%) -42.47 -191.42 391.38 -37.07 -129.05 815.97 -8.98 -40.33 -48.56 -198.13 588.7
PAT Growth(%) -158.41 -229.4 148.82 -268.53 -61.83 150.68 -86.03 -676.94 -301.38 -5.37 159.44
EPS Growth(%) -158.41 -105.41 195.08 -206.24 -72.8 156.31 -53 -228.42 -338.02 -117.72 244.47
Debt/Equity(x) 0.71 0.72 0.75 0.85 0.95 0.83 0.79 0.84 0.84 1.14 0.51
Current Ratio(x) 1.28 1.16 1.08 0.98 1.07 1.22 1.23 1.12 1.09 0.98 0.9
Quick Ratio(x) 0.97 0.81 0.7 0.57 0.62 0.78 0.61 0.57 0.53 0.55 0.56
Interest Cover(x) 0.9 -0.57 1.4 0.58 -0.17 1.35 1.49 0.66 0.28 -0.39 1.83
Total Debt/Mcap(x) 1.83 1.37 1.53 1.87 5.14 1.23 0.79 1.09 1.1 1.82 1.18

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +30% -15% -2% +6%
Operating Profit CAGR +92% +4% -2% +7%
PAT CAGR — — +15% —
Share Price CAGR +110% +12% -2% +7%
ROE Average +6% -4% -3% -2%
ROCE Average +6% +2% +2% +2%

Kanoria Chem. & Inds Shareholding Pattern

Latest · Sep 2026
100% held
Promoters 74.4 %
FII 0.03 %
DII (MF + Insurance) 0.11 %
Public (retail) 25.46 %
# Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Promoter 74.474.474.474.474.474.474.474.474.474.4
FII 0.160.010.010.020.010000.010.03
DII 0.110.110.110.110.110.110.110.110.110.11
Public 25.3325.4825.4825.4725.4825.4925.4925.4925.4825.46
Others 0000000000
Total 100100100100100100100100100100

Kanoria Chem. & Inds Peer Comparison

Chemicals Edit Columns

Kanoria Chem. & Inds Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Kanoria Chem. & Inds Pros & Cons

Pros

  • Debtor days have improved from 153.8 to 93.94days.
  • Company has reduced debt.

Cons

  • Company has a low return on equity of -4% over the last 3 years.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp